Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple dermatofibromata developing during pregnancy

J Stainforth1, M J Goodfield

  • 1Department of Dermatology, General Infirmary at Leeds, UK.

Clinical and Experimental Dermatology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.

The British journal of dermatology·2020
Same author

An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).

The British journal of dermatology·2020
Same author

Validity and sensitivity to change of laser Doppler imaging as a novel objective outcome measure for cutaneous lupus erythematosus.

Lupus·2019
Same author

Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaire.

Lupus science & medicine·2015
Same author

Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus.

The Journal of dermatological treatment·2002
Same author

PUVA therapy in lichen aureus.

Journal of the American Academy of Dermatology·2001
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
Same journal

Male genital fixed drug eruption: a systematic review.

Clinical and experimental dermatology·2026
See all related articles

Multiple dermatofibromata, benign skin tumors, can occur during pregnancy due to altered immunity. This case highlights a potential link between pregnancy and the development of these common dermal growths.

Area of Science:

  • Dermatology
  • Oncology
  • Immunology

Background:

  • Dermatofibromata are common benign dermal tumors with unknown causes.
  • Typically, they appear as solitary lesions on the limbs of young adults.
  • Multiple lesions are rare and have been associated with autoimmune diseases and immunosuppressive therapy.

Observation:

  • A case study of a 25-year-old female experiencing her first pregnancy is presented.
  • The patient developed multiple dermatofibromata during this period.
  • Pregnancy is a state characterized by significant alterations in the immune system.

Findings:

  • The development of multiple dermatofibromata in a pregnant patient suggests a potential association.
  • Altered immune status during pregnancy may play a role in the proliferation of these dermal neoplasms.

Related Experiment Videos

  • This case expands the known associations of multiple dermatofibromata beyond autoimmune conditions.

    • Implications:

    • Further research is warranted to explore the immunological factors influencing dermatofibromata development during pregnancy.
    • Understanding this link could lead to new insights into benign skin tumor formation.
    • This observation may prompt closer dermatological monitoring in pregnant individuals with a history of skin lesions.